LONE STAR FUNDS to acquire CAPSUGEL HOLDINGS US

Lone Star Funds has agreed to acquire Capsugel Holdings US on 13 April 2026. The transaction involves a target operating within the pharmaceutical manufacturing sector, classified under NaceV2Sector_C_21. The deal value and specific consideration terms have not been disclosed to the public. Consequently, the financial structure of the acquisition remains unknown at this stage. No information regarding the target country of operation is available in the current records. The deal type has not been explicitly categorised in the provided data set.

The transaction is currently in the review phase with a status of in review. Regulatory approval and other standard conditions remain outstanding before completion can occur. The deal has not yet been finalised as the completion date is not reported. Further details regarding the strategic rationale or specific financial figures are not available for inclusion. Stakeholders await the outcome of the ongoing review process to determine the final outcome of the acquisition.